Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth-quarter financial results for 2023 and data on their orthopedic sales.
Here is how they compare:
Total sales: $5.8 billion (+11.8%)
Orthopedics: $2.4 billion (+11%)
Hips: $414 million (+10.2%)
Knees: $630 million (+14.2%)
Spine: $318 million (+7%)
Total sales: $1.9 billion (+6.3%)
Hips: $504.8 million (+3.3%)
Knees: $798.3 million (+5.9%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $453.3 million (+6.9%)
Total sales: $21.4 billion (+7.3%)
Spine, sports and other: $742 million (+6.2%)
Orthopedic: $2.3 billion (+5.6%)
Hips: $398 million (+3.4%)
Knees: $387 million (+9.2%)
Subscribe to the following topics: strykerjohnson & johnsonzimmer biometfourth-quarterfinancial results